News

Discover the latest advancements in CSU treatment, including new therapies and evolving management strategies for better patient outcomes.

Spizuoco leads the inaugural DermVIP Summit, enhancing alopecia education for dermatology professionals through expert insights and innovative treatments.

Pediatric dermatology experiences a transformative shift, enhancing care for younger patients and expanding therapeutic options.

John Barbieri, MD, MBA; Ted Rosen, MD; Peter Lio, MD; Shanna Miranti, MPAS, PA-C; and Larissa Schmidt, DPM, share what gifts they would give to the field of dermatology this holiday season.

As 2025 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.

Brad Glick, DO, MPH, and attendees discuss innovative treatments for atopic dermatitis, emphasizing the importance of patient comfort and modern nonsteroidal options.

Discover the latest advancements in hidradenitis suppurativa therapies, including promising biologics and oral treatments reshaping patient care in 2025.

Erik Domingues leads a vital discussion on innovative vitiligo management, addressing treatment challenges and psychosocial impacts in diverse patient populations.

Hilary Baldwin, MD; Douglas DiRuggiero, DMSc, MHS, PA-C; Diego Ruiz DaSilva, MD; Ken Korber, PA-C; Patrick Burnett, MD, PhD; and Lisa Weiss, PA-C, share what gifts they would give to the field of dermatology this holiday season.

Experts discuss innovative strategies for vitiligo treatment, emphasizing the role of topical Janus kinase inhibitors and effective patient communication for optimal outcomes.

Discover how NPs and PAs shaped the future of dermatology this year as leaders inspire the next generation to thrive in their careers.

Michael O'Donoghue, MD, shares insights on actinic keratosis management, emphasizing personalized therapy strategies.

At a recent Case-Based Roundtable event, Harrison Nguyen, MD, MBA, MPH, reviewed 2 HS patient cases and discussed the role of biologics.

Find out what skin care products and aesthetic innovations clinicians have recommended to patients in 2025.

A mother shares her personal journey with her daughter's chronic spontaneous urticaria, highlighting the emotional and treatment challenges faced by families.

Explore our top performing social media posts of 2025, including insights on the latest clinical trials, FDA approvals, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

In case you missed it, this week we had news on phase 3 data for zasocitinib in psoriasis, wildfire air pollution's impact on AD clinic visits, the FDA's clearance of REX-8756's IND application, and more.

In part 3 of this supplement, experts discuss treatment options for adults with hormonal pattern acne and PIH.

Discover effective treatment strategies for keloids and hypertrophic scars in skin of color, emphasizing personalized approaches and combination therapies.

Energy and protein drinks may exacerbate acne through high sugar and insulin levels, impacting skin health among athletes and students.

Discover the latest trends in aesthetic dermatology for 2025, including innovative treatments and the impact of social media on patient choices.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of December.

Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed the 3 latest non-steroidal topicals for atopic dermatitis at the Horizons in Advanced Practice meeting.

Experts discuss real-world strategies for managing alopecia areata, emphasizing JAK inhibitors, psychosocial impacts, and personalized patient care approaches.

What were the top dermatology hits of 2025?

In part 3 of this Case-Based Roundtable supplement, experts discuss psoriatic therapies for hair-baring areas.